These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31258466)

  • 1. Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography.
    Sala A; Perani D
    Front Neurosci; 2019; 13():617. PubMed ID: 31258466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Molecular Connectivity in Neurodegenerative Conditions.
    Carli G; Tondo G; Boccalini C; Perani D
    Brain Sci; 2021 Mar; 11(4):. PubMed ID: 33800680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies.
    Perani D; Iaccarino L; Lammertsma AA; Windhorst AD; Edison P; Boellaard R; Hansson O; Nordberg A; Jacobs AH;
    Alzheimers Dement; 2019 Aug; 15(8):1081-1103. PubMed ID: 31230910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid PET/MR Imaging and Brain Connectivity.
    Aiello M; Cavaliere C; Salvatore M
    Front Neurosci; 2016; 10():64. PubMed ID: 26973446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid PET-MRI Applications in Movement Disorders.
    Tondo G; Esposito M; Dervenoulas G; Wilson H; Politis M; Pagano G
    Int Rev Neurobiol; 2019; 144():211-257. PubMed ID: 30638455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic connectivity: methods and applications.
    Yakushev I; Drzezga A; Habeck C
    Curr Opin Neurol; 2017 Dec; 30(6):677-685. PubMed ID: 28914733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
    Høilund-Carlsen PF
    Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of PET imaging in dementia.
    Iaccarino L; Sala A; Caminiti SP; Perani D
    F1000Res; 2017; 6():1830. PubMed ID: 29071066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau PET imaging: present and future directions.
    Saint-Aubert L; Lemoine L; Chiotis K; Leuzy A; Rodriguez-Vieitez E; Nordberg A
    Mol Neurodegener; 2017 Feb; 12(1):19. PubMed ID: 28219440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Amyloid PET Imaging Biomarkers for Neurodegeneration: Focus on Tau, Alpha-Synuclein and Neuroinflammation.
    Catafau AM; Bullich S
    Curr Alzheimer Res; 2017; 14(2):169-177. PubMed ID: 27334945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future Directions in Molecular Imaging of Neurodegenerative Disorders.
    Barthel H; Villemagne VL; Drzezga A
    J Nucl Med; 2022 Jun; 63(Suppl 1):68S-74S. PubMed ID: 35649650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.
    Rodriguez-Vieitez E; Nordberg A
    Methods Mol Biol; 2018; 1750():231-251. PubMed ID: 29512077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Positron emission tomography : from classical indications to new and future applications].
    Goldman S; El Darazi E; Mathey C; Muteganya R
    Rev Med Brux; 2018; 39(4):220-226. PubMed ID: 30320981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET-based brain molecular connectivity in neurodegenerative disease.
    Hanania JU; Reimers E; Bevington CWJ; Sossi V
    Curr Opin Neurol; 2024 Aug; 37(4):353-360. PubMed ID: 38813843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Brain Network Connectivity Patterns Associated With Normal Cognition at Old-Age, Local β-amyloid, Tau, and APOE4.
    Quevenco FC; van Bergen JM; Treyer V; Studer ST; Kagerer SM; Meyer R; Gietl AF; Kaufmann PA; Nitsch RM; Hock C; Unschuld PG
    Front Aging Neurosci; 2020; 12():46. PubMed ID: 32210782
    [No Abstract]   [Full Text] [Related]  

  • 16. PET/MR in dementia and other neurodegenerative diseases.
    Barthel H; Schroeter ML; Hoffmann KT; Sabri O
    Semin Nucl Med; 2015 May; 45(3):224-33. PubMed ID: 25841277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New PET markers for the diagnosis of dementia.
    Payoux P; Salabert AS
    Curr Opin Neurol; 2017 Dec; 30(6):608-616. PubMed ID: 28906268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule PET Tracers for Imaging Proteinopathies.
    Mathis CA; Lopresti BJ; Ikonomovic MD; Klunk WE
    Semin Nucl Med; 2017 Sep; 47(5):553-575. PubMed ID: 28826526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals.
    Schultz AP; Chhatwal JP; Hedden T; Mormino EC; Hanseeuw BJ; Sepulcre J; Huijbers W; LaPoint M; Buckley RF; Johnson KA; Sperling RA
    J Neurosci; 2017 Apr; 37(16):4323-4331. PubMed ID: 28314821
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.